 A hidden culprit behind diabetes could unlock a new wave of treatments. Stay with me for the big reveal. No, this is not old news. This is based from a recent study. Let's go. Researchers have identified an enzyme that sabotages insulin, offering a potential target to control this widespread disease. Nitric oxide, a molecule known for its many benefits, holds a dark secret. This study, led by Dr. Jonathan Stamler, a distinguished professor at Case Western Reserve and president of Harrington Discovery Institute that was published in Cell, reveals how an enzyme called scan attaches nitric oxide to the insulin receptor, disrupting its vital role in managing blood sugar. Mice lacking the scan enzyme showed remarkable resistance to diabetes, highlighting its causal role. Stamler suggests this breakthrough extends beyond diabetes, pointing to potential treatments for Alzheimer's, cancer, and heart failure, where excessive nitric oxide binding also plays a role. By identifying a specific enzyme responsible for disrupting insulin, this research sheds light on a previously unclear mechanism in diabetes development. With an enzyme target identified, the stage is set for designing medications to block scan and restore insulin's effectiveness. This promising discovery paves the way for a new era of diabetes management and potentially offers therapeutic hope for a range of other diseases linked to excessive nitric oxide activity. Consider PEMF therapy as part of your wellness journey, with our advanced key coils setting the standard in the market. Our potent audio frequencies embody mathematical representations of consciousness states, emotions, and physical well-being for a healthier new you. DM us to explore the world of frequency healing with guidance from a certified frequency expert.